Pages that link to "Q33886927"

The following pages link to Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses (Q33886927):

Displaying 30 items.

• Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach (Q27316846) (← links)
• The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis? (Q28068521) (← links)
• Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers (Q30151193) (← links)
• NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets (Q30394706) (← links)
• New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges (Q30407424) (← links)
• Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner (Q30429134) (← links)
• The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly (Q33622358) (← links)
• Innate immune evasion strategies of influenza viruses (Q33646273) (← links)
• Animal models for influenza viruses: implications for universal vaccine development (Q34809686) (← links)
• Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype (Q34992691) (← links)
• A Systematic Review of Recent Advances in Equine Influenza Vaccination (Q35826722) (← links)
• Equine influenza – surveillance and control (Q36252628) (← links)
• Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies. (Q36327122) (← links)
• Blocking interhost transmission of influenza virus by vaccination in the guinea pig model (Q37127910) (← links)
• Attenuation of the virulence of a recombinant influenza virus expressing the naturally truncated NS gene from an H3N8 equine influenza virus in mice (Q37417018) (← links)
• Facing the threat of equine influenza (Q37865053) (← links)
• Equine influenza--a global perspective (Q38107292) (← links)
• Time-related Pathological Changes in Horses Experimentally Inoculated with Equine Influenza A Virus (Q39369800) (← links)
• Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene (Q41749152) (← links)
• Whole genome sequencing and antigenic analysis of the first equine influenza virus identified in Turkey. (Q41931629) (← links)
• Replication of avian influenza viruses in equine tracheal epithelium but not in horses (Q42253252) (← links)
• Avian influenza virus NS1: A small protein with diverse and versatile functions (Q42724653) (← links)
• Assessment of correlation between in vitro CD3+ T cell susceptibility to EAV infection and clinical outcome following experimental infection (Q45060067) (← links)
• Development of a novel equine influenza virus live-attenuated vaccine. (Q50054245) (← links)
• Report of the International Equine Influenza Roundtable Expert Meeting at Le Touquet, Normandy, February 2013. (Q51823288) (← links)
• A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus. (Q55237420) (← links)
• Live Attenuated Influenza Virus Vaccines: NS1 Truncation as an Approach to Virus Attenuation (Q56879900) (← links)
• A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies (Q56970558) (← links)
• Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins (Q60959439) (← links)
• Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens (Q82461827) (← links)